Topics such as the Affordable Care Act and drug pricing are expected to be included in policy proposals and debates leading up to the November election. “In the near term, these issues pose headline risk to healthcare equity prices that may influence capital deployment decisions,” according to Fitch.
Over the longer term, the upcoming election will have a significant effect on the healthcare industry, as change to the legislative and political environment could cause disruption to business models, according to Fitch.
The viability of public health insurance exchanges is one issue that hinges on the election. “Vibrant exchange marketplaces with adequate competition to ensure rational pricing would likely be the best case scenario for healthcare providers and, by extension, the rest of the U.S. healthcare industry. This is more likely to occur with a balance of power that favors Democrats,” stated Fitch.
More articles on healthcare finance:
Chinese billionaire ups stake in CHS for $31.9M
7 hospitals receive credit downgrades in past month
Erlanger reports net surplus, gives 3,700 employees bonuses
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
